Ozempic / Wegovy Programs
Physician-guided semaglutide programmes for diabetes and weight loss.
Ozempic and Wegovy in India are brand names for semaglutide, a GLP-1 medicine that lowers blood sugar and supports weight loss. Ozempic is used mainly for type 2 diabetes and Wegovy for weight management, and at EDFC both are prescribed and monitored by our physicians.
What is the difference between Ozempic and Wegovy?
Both contain semaglutide, the same active molecule, at different approved doses and for different primary uses. Ozempic is licensed for type 2 diabetes, while Wegovy is licensed for chronic weight management. Your doctor decides which fits your goals. Both belong to the GLP-1 class of therapies.
Who is semaglutide suitable for?
Semaglutide is prescription only and is considered for selected adults with type 2 diabetes or weight related health risk, after a full review. It is not right for everyone, and our team checks suitability and availability first. Early nausea is common and usually settles. The International Diabetes Federation supports weight loss as a key goal in type 2 diabetes care.
Why choose EDFC for Ozempic and Wegovy in India?
We guide dosing, manage side effects and track results against your HbA1c and body composition, not the scale alone. Compare with our Mounjaro programme or view all advanced therapies. Book a review with our clinic team. This page is educational and not a substitute for a consultation.